Abstract: The present disclosure relates to a method of preparing a polymer, which includes: adding an alkyl-substituted aromatic vinyl-based monomer and a vinyl cyanide-based monomer to a reactor and initiating polymerization; and performing polymerization while continuously adding an alkyl-substituted aromatic vinyl-based monomer and a multifunctional initiator to the reactor, wherein the continuous addition of the alkyl-substituted aromatic vinyl-based monomer and the multifunctional initiator is initiated when a polymerization conversion rate is 10 to 30%, and the continuous addition of the alkyl-substituted aromatic vinyl-based monomer and the multifunctional initiator is terminated when a polymerization conversion rate is 70 to 80%.

Abstract: A display device comprises a display area and a non-display area, sub-pixels in the display area, each sub-pixel including a first electrode and a second electrode extended in a first direction and light-emitting elements disposed on the first electrode and the second electrode, sub-lines disposed in the non-display area and extended in a second direction, and conductive patterns extended in the first direction, each conductive pattern being connected to at least one of the plurality of sub-lines. The sub-lines comprise first, second, and third sub-lines sequentially disposed from the first sub-line toward the display area. The conductive patterns are disposed in at least one of the sub-pixels closest to the sub-lines. The conductive patterns comprise a first conductive pattern connected to the first sub-line, second conductive patterns connected to the second sub-line, and a third conductive pattern connected to the third sub-line.

Abstract: The present application relates to a novel strain of the genus Schizochytrium (Schizochytrium sp.) and a method of producing polyunsaturated fatty acids by using the same. According to one aspect, novel microalgae of the genus Schizochytrium have a high content of fat in biomass, and particularly, a high content of polyunsaturated fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and therefore, the microalgae, and biomass or bio-oil prepared therefrom, may be useful as a feed source or the like.

Abstract: An inkjet printing apparatus includes a stage on which a target substrate is mounted, and an inkjet head positioned above the stage, wherein the inkjet head includes an ejection part including a plurality of nozzles that spray ink containing a plurality of particles, a filter part disposed above the ejection part, and selectively passing the plurality of particles, and an electric field generating electrode that is disposed in the filter part and generates an electric field in the filter part.

Abstract: The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.

Abstract: The present invention relates to a composition for screening various signal peptides to select specific ones that allow efficient secretion of a target protein to out of host cells. The present invention also relates to a method for selecting specific signal peptides that express a target protein in host cells and efficiently secrete the target protein to out of the host cells. The use of the composition and/or method according to the present invention enables ultrafast selection of optimal signal peptides for a target protein through barcoding sequences corresponding to the signal peptides, leading to the maximization of the production yield of the recombinant protein.

Abstract: The present invention relates to a composition comprising albumin-bound Slit3 LRRD2 for prevention or treatment of a muscle disease, and more particularly provides a fusion protein comprising albumin-bound Slit3 LRRD2, a nucleic acid molecule encoding the fusion protein, a recombinant vector comprising the nucleic acid molecule, a transformant comprising the recombinant vector, a method for preparing a fusion protein using the transformant, a composition comprising the fusion protein for prevention or treatment of a muscle disease, and a composition comprising the fusion protein for improving the in vivo half-life of LRRD2 of the Slit 3 protein.

Abstract: The present invention relates to a composition comprising albumin-bound LRRD2 of the SLIT3 protein for prevention or treatment of bone-related diseases.

Abstract: Melanophilin (MLPH) of the present invention is involved in differentiation into an adipocyte or fat accumulation, and accordingly, obesity can be treated or prevented by inhibiting the MLPH. Further, by measuring an expression level of the MLPH, obesity can be diagnosed and treated, and therapeutic agents for obesity and agents regulating differentiation into adipocytes can be screened.

Abstract: Melanophilin (MLPH) of the present invention is involved in differentiation into an adipocyte or fat accumulation, and accordingly, obesity can be treated or prevented by inhibiting the MLPH. Further, by measuring an expression level of the MLPH, obesity can be diagnosed and treated, and therapeutic agents for obesity and agents regulating differentiation into adipocytes can be screened.

Abstract: The present invention relates to a method and an elevator system for monitoring elevators by using a virtual elevator group. The method for monitoring elevators in an elevator system including a plurality of elevators classified into a plurality of elevator groups, and at least one virtual elevator group including a plurality of elevators, at least one of which is included in a different elevator group and displaying the elevator related information on the elevators included in the selected virtual elevator group.

Abstract: The present invention relates to a pyridazinone derivative which can be used as a caspase inhibitor, process for the preparation thereof, and pharmaceutical composition for inhibiting caspase comprising the same.

Abstract: The present invention relates to a pyridone derivative which can be used as a caspase inhibitor, process for the preparation thereof, and pharmaceutical composition for inhibiting caspase comprising the same.

Abstract: The present invention relates to an isoxazoline derivative as an inhibitor against various caspases, a process for preparing the same, and a therapeutic composition for preventing inflammation and apoptosis comprising the same.

Abstract: The present invention relates to a method and an elevator system for monitoring elevators by using a virtual elevator group. The method for monitoring elevators in an elevator system including a plurality of elevators classified into a plurality of elevator groups, and at least one virtual elevator group including a plurality of elevators, at least one of which is included in a different elevator group and displaying the elevator related information on the elevators included in the selected virtual elevator group.

Abstract: The present invention relates to an isoxazoline derivative as an inhibitor against various caspases, a process for preparing the same, and a therapeutic composition for preventing inflammation and apoptosis comprising the same